CVS Health Stock Performance and Analyst Outlook
CVS Health (CVS) has underperformed the broader market over the past 52 weeks, with a 21.1% increase compared to the S&P 500's 29.8% gain. The company reported a decline in Q4 2025 adjusted EPS and operating income, driven by goodwill impairment and litigation costs, despite record revenue. Analysts expect a 5.8% growth in adjusted EPS for 2026.
Tickers: $CVS
Topics: Analyst Expectations CVS Health Earnings Market Performance Stock Outlook